The invention provides highly purified �-Gal A, and various methods for purifying it; �-Gal A preparations with altered charge and methods for making those preparations; �-Gal A preparations that have an extended circulating half-life in a mammalian host, and methods for making same; and methods and dosages for administering an �-Gal A preparation to a subject.
申请公布号
CA2833396(A1)
申请公布日期
2000.09.14
申请号
CA20002833396
申请日期
2000.03.09
申请人
SHIRE HUMAN GENETIC THERAPIES, INC.
发明人
SELDEN, RICHARD F.;BOROWSKI, MARIANNE;KINOSHITA, CAROL M.;TRECO, DOUGLAS A.;WILLIAMS, MELANIE D.;SCHUETZ, THOMAS J.;DANIEL, PETER FRANCIS